Diamyd Medical Aktiebolag produces pharmaceuticals and medical vaccines. The Company develops diabetes vaccines for the treatment and prevention of auto-immune diabetes. Diamyd Medical also invests in stem cell and medical technology.
Every round, secondary, debt facility or acquisition involving Diamyd Medical that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.